Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Artiva Biotherapeutics Inc.

United States 5505 Morehouse Drive Suite 100, 92121-1720, United States

About the sponsor

Clinical research activity is centered on difficult-to-treat rheumatic diseases, with interest in conditions driven by persistent immune dysregulation and chronic inflammation.

  • Rheumatoid Arthritis
  • Idiopathic Inflammatory Myopathies
  • Sjögren’s Disease
  • Systemic Sclerosis

The sponsor’s portfolio reflects a focus on autoimmune disorders where joint, muscle, glandular, and connective tissue involvement can create substantial disease burden.

About Specializations

Artiva Biotherapeutics Inc. runs clinical trials in conditions such as Systemic scleroderma, Rheumatoid arthritis, Sjogren's syndrome, Myopathy, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Systemic scleroderma+3

Not recruiting

Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Artiva Biotherapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.